| Mrs Rachel Deann Fitch, LISW-S | |
|
11156 Canal Rd, Cincinnati, OH 45241-5815 | |
| (513) 772-6166 | |
| (513) 772-6177 |
| Full Name | Mrs Rachel Deann Fitch |
|---|---|
| Gender | Female |
| Speciality | Social Worker - Clinical |
| Location | 11156 Canal Rd, Cincinnati, Ohio |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013105469 | NPI | - | NPPES |
| 1013105469 | Other | OH | NPI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | 1302814 (Ohio) | Primary |
| Entity Name | National Youth Advocate Program Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1679721906 PECOS PAC ID: 7719258292 Enrollment ID: O20170801003093 |
News Archive
OSI Pharmaceuticals, Inc. announced today that the U.S. Patent & Trademark Office has issued a "Notice of Allowance" in OSI's reissue application for U.S. Patent No.5,747,498 (the ‘498) composition of matter patent for Tarceva® (erlotinib). The reissued patent will replace the original ‘498 patent and have the same November 2018 expiration date.
The first clinical trial to test a newly approved breast cancer drug specifically in African American patients is now enrolling at Georgetown Lombardi Comprehensive Cancer Center and will begin soon at five other institutions in Washington, DC, Maryland, Alabama and New Jersey.
A study in rats shows that exposure to a high-fat diet during pregnancy produces permanent changes in the offspring's brain that lead to overeating and obesity early in life, according to new research by Rockefeller University scientists.
The Damon Runyon Cancer Research Foundation, a non-profit organization focused on supporting innovative early career researchers, named the first recipients of the Dale F. Frey Award for Breakthrough Scientists. This new award provides additional funding to scientists completing a prestigious Damon Runyon Fellowship Award who have greatly exceeded the Foundation's highest expectations and are most likely to make paradigm-shifting breakthroughs that transform the way we prevent, diagnose and treat cancer.
Leading the development of endovascular aortic repair (EVAR), Medtronic, Inc. today announced the start of its U.S. post-approval study of the Endurant AAA Stent Graft System, a medical device used to treat abdominal aortic aneurysms.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Rachel Deann Fitch, LISW-S 11156 Canal Rd, Cincinnati, OH 45241-5815 Ph: (513) 772-6166 | Mrs Rachel Deann Fitch, LISW-S 11156 Canal Rd, Cincinnati, OH 45241-5815 Ph: (513) 772-6166 |
News Archive
OSI Pharmaceuticals, Inc. announced today that the U.S. Patent & Trademark Office has issued a "Notice of Allowance" in OSI's reissue application for U.S. Patent No.5,747,498 (the ‘498) composition of matter patent for Tarceva® (erlotinib). The reissued patent will replace the original ‘498 patent and have the same November 2018 expiration date.
The first clinical trial to test a newly approved breast cancer drug specifically in African American patients is now enrolling at Georgetown Lombardi Comprehensive Cancer Center and will begin soon at five other institutions in Washington, DC, Maryland, Alabama and New Jersey.
A study in rats shows that exposure to a high-fat diet during pregnancy produces permanent changes in the offspring's brain that lead to overeating and obesity early in life, according to new research by Rockefeller University scientists.
The Damon Runyon Cancer Research Foundation, a non-profit organization focused on supporting innovative early career researchers, named the first recipients of the Dale F. Frey Award for Breakthrough Scientists. This new award provides additional funding to scientists completing a prestigious Damon Runyon Fellowship Award who have greatly exceeded the Foundation's highest expectations and are most likely to make paradigm-shifting breakthroughs that transform the way we prevent, diagnose and treat cancer.
Leading the development of endovascular aortic repair (EVAR), Medtronic, Inc. today announced the start of its U.S. post-approval study of the Endurant AAA Stent Graft System, a medical device used to treat abdominal aortic aneurysms.
› Verified 3 days ago
June Huelskamp, LISW-S Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 7439 Montgomery Rd, Suite 4, Cincinnati, OH 45236 Phone: 513-607-5448 Fax: 513-745-9651 | |
Ms. Patricia Brown, LISW/LICDC Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 311 Martin Luther King Dr E, Cincinnati, OH 45219 Phone: 513-475-5300 Fax: 513-281-2571 | |
Crysta Fletcher, LISW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 3284 North Bend Rd, Suite 314, Cincinnati, OH 45239 Phone: 513-481-2432 Fax: 513-662-2432 | |
Mary Elizabeth Lloyd, APRN Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 4015 Executive Park Dr Ste 320, Cincinnati, OH 45241 Phone: 513-563-0488 | |
Marj'ohnna M Harris, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1628 Iliff Ave, Cincinnati, OH 45205 Phone: 513-413-8424 | |
Richard A. Kasper, LISW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 2330 Victory Pkwy, Ste 500, Cincinnati, OH 45206 Phone: 513-221-2330 Fax: 513-221-8954 | |
Monica Terese Vonahlefeld, LSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 3333 Burnet Avenue, Cincinnati, OH 45226 Phone: 513-636-9307 Fax: 513-636-9569 |